🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)

Recruitingn/aAges 65 Years - anyAllIstituto Nazionale di Ricovero e Cura per Anziani
NCT06904638 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Geriatric ward admission or outpatient geriatric appointment * Capacity to provide informed consent by the patient or legal guardian Exclusion Criteria: * Limited life expectancy as measured by the Clinical Frailty Scale (CFS) \>8
💊

What it tests

  • Not listed
📍

Where

2 sites
IRCCS INRCA Hospital
Ancona, Italy
IRCCS INRCA Hospital
Cosenza, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy